JP2002255933A - Method for producing optically active 7-amino-5- azaspiro[2.4]heptane - Google Patents

Method for producing optically active 7-amino-5- azaspiro[2.4]heptane

Info

Publication number
JP2002255933A
JP2002255933A JP2001050384A JP2001050384A JP2002255933A JP 2002255933 A JP2002255933 A JP 2002255933A JP 2001050384 A JP2001050384 A JP 2001050384A JP 2001050384 A JP2001050384 A JP 2001050384A JP 2002255933 A JP2002255933 A JP 2002255933A
Authority
JP
Japan
Prior art keywords
group
amino
formula
optically active
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001050384A
Other languages
Japanese (ja)
Inventor
Makoto Muto
真 武藤
Takashi Nakayama
敬司 中山
Toshifumi Akiba
敏文 秋葉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Priority to JP2001050384A priority Critical patent/JP2002255933A/en
Publication of JP2002255933A publication Critical patent/JP2002255933A/en
Pending legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

PROBLEM TO BE SOLVED: To provide a method for producing an optically active 7-amino-5- azaspiro[2.4]heptane which is a raw material for synthesizing antibacterial compounds. SOLUTION: This method for producing the 7-amino-5-azaspiro[2.4]heptane is characterized by reacting a compound represented by formula (1) (R<1> is H or an amino-protecting group) with a compound represented by the formula: R<2> -NH2 (R<2> is H or an amino-protecting group) in the presence of an acid, hydrogenating the produced compound represented by formula (2) (R<1> and R<2> are each independently the same as described above) in the presence of an asymmetric catalyst, and, if desired, removing the protecting group. The highly optically pure 7-amino-5-azaspiro[2.4]heptane having a high optical purity can be produced using a catalytic amount of the asymmetric source in a high yield.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、抗菌化合物の合成
原料物質である光学活性7−アミノ−5−アザスピロ
[2.4]ヘプタンの製造法に関する。
TECHNICAL FIELD The present invention relates to a method for producing optically active 7-amino-5-azaspiro [2.4] heptane, which is a raw material for synthesizing antibacterial compounds.

【0002】[0002]

【従来の技術】光学活性7−アミノ−5−アザスピロ
[2.4]ヘプタンは抗菌性化合物の製造中間体として
有用である(特開平2−231475号公報、特開平5
−221947号公報)。その合成法としてラセミのア
ミン類と光学活性な酸による分割晶析法が提案されてい
る(特開平4−149174号公報、特開平7−224
033号公報)。しかしながら、この方法では一方の光
学活性体が不要となり、不要の異性体を活用するため
に、ラセミ化反応(特開平4−342565号公報、特
開平7−233146号公報)等の対応が必要であっ
た。
2. Description of the Related Art Optically active 7-amino-5-azaspiro [2.4] heptane is useful as an intermediate for producing an antibacterial compound (JP-A-2-231475, JP-A-5-231475).
221947). As a synthesis method thereof, a split crystallization method using racemic amines and an optically active acid has been proposed (JP-A-4-149174, JP-A-7-224).
No. 033). However, this method does not require one of the optically active isomers, and it is necessary to take measures such as a racemization reaction (JP-A-4-342565, JP-A-7-233146) in order to utilize the unnecessary isomer. there were.

【0003】[0003]

【発明が解決しようとする課題】近年、不斉金属錯体を
触媒とする不斉合成法の報告が数多くなされ、有機合成
反応の高効率化を実現している。これに伴い、光学活性
スピロアミン化合物の不斉合成法の開発が望まれてい
た。本発明の目的は、不斉合成を利用した光学活性の7
−アミノ−5−アザスピロ[2.4]ヘプタンの製造法
を提供することにある。
In recent years, there have been many reports on asymmetric synthesis methods using asymmetric metal complexes as catalysts, and have realized high efficiency of organic synthesis reactions. Accordingly, development of an asymmetric synthesis method for optically active spiroamine compounds has been desired. An object of the present invention is to provide a compound having an optical activity of 7 using asymmetric synthesis.
-Amino-5-azaspiro [2.4] heptane.

【0004】[0004]

【課題を解決するための手段】そこで本発明者は、種々
検討した結果、式(1)で表わされるケトン化合物を原
料とし、これに酸存在下でアミン化合物を反応させて式
(2)のイミン化合物を製造し、次いで不斉触媒存在下
で水素還元して光学活性化合物に変換し、さらに、これ
が保護基を有する場合には脱保護することにより、高収
率で光学活性7−アミノ−5−アザスピロ[2.4]ヘ
プタン(式(4))が得られることを見出し、本発明を
完成した。
The inventors of the present invention have conducted various studies and found that a ketone compound represented by the formula (1) was used as a raw material, and this was reacted with an amine compound in the presence of an acid to form a compound represented by the formula (2). An imine compound is produced and then reduced with hydrogen in the presence of an asymmetric catalyst to convert the compound into an optically active compound, and when this has a protective group, it is deprotected, so that the optically active 7-amino- It was found that 5-azaspiro [2.4] heptane (formula (4)) was obtained, and the present invention was completed.

【0005】すなわち、本発明は、次式(1)That is, the present invention provides the following formula (1)

【0006】[0006]

【化12】 Embedded image

【0007】(式中、R1は水素原子又はアミノ基の保
護基を示す。)で表わされる化合物に、酸存在下で、式
2−NH2(式中、R2は水素原子又はアミノ基の保
護基を示す。)で表わされる化合物を反応させ、得られ
た式(2)
[0007] (In the formula, R 1. Indicating a hydrogen atom or a protective group for an amino group) into the compound represented by, in the presence of an acid, wherein R 2 -NH 2 (wherein, R 2 is a hydrogen atom or an amino A compound represented by the formula (2):

【0008】[0008]

【化13】 Embedded image

【0009】(式中、R1及びR2は各々独立して前記と
同じ。)で表わされる化合物を、式MXmn(式中、M
は周期律表8〜10族の遷移金属、Xは水素原子、ハロ
ゲン原子、アルコキシ基、アルケニル基又はアリール
基、Lは光学活性ホスフィン配位子を示し、m及びnは
各々0〜6の整数を示す。)で表わされる不斉触媒の存
在下で還元し、得られた式(3)
(Wherein R 1 and R 2 are each independently the same as defined above) by the formula MX m L n (wherein M
Is a transition metal of Groups 8 to 10 of the periodic table, X is a hydrogen atom, a halogen atom, an alkoxy group, an alkenyl group or an aryl group, L is an optically active phosphine ligand, and m and n are each an integer of 0 to 6 Is shown. ) In the presence of an asymmetric catalyst represented by the formula (3)

【0010】[0010]

【化14】 Embedded image

【0011】(式中、R1及びR2は各々独立して前記と
同じ。)で表わされる光学活性化合物を所望により脱保
護することを特徴とする式(4)
(Wherein R 1 and R 2 are each independently the same as described above), wherein the optically active compound represented by the formula (4) is optionally deprotected.

【0012】[0012]

【化15】 Embedded image

【0013】で表わされる光学活性化合物の製造法を提
供するものである。また、本発明は、式(2)で表わさ
れる化合物及び式(2)〜(4)で表わされる化合物の
製造法を提供するものである。
[0013] It is intended to provide a method for producing an optically active compound represented by the formula: The present invention also provides a method for producing the compound represented by the formula (2) and the compounds represented by the formulas (2) to (4).

【0014】[0014]

【発明の実施の形態】本発明の光学活性な7−アミノ−
5−アザスピロ[2.4]ヘプタン(4)は、次の反応
経路で製造される。
DETAILED DESCRIPTION OF THE INVENTION The optically active 7-amino- of the present invention.
5-Azaspiro [2.4] heptane (4) is produced by the following reaction route.

【0015】[0015]

【化16】 Embedded image

【0016】(式中、R1及びR2は前記と同じ。)(Wherein R 1 and R 2 are the same as above)

【0017】ここで、R1及びR2がアミノ基の保護であ
る場合、当該保護基としては、t−ブトキシカルボニル
基、メトキシカルボニル基、エトキシカルボニル基及び
2,2,2−トリクロロエトキシカルボニル基等のアル
コキシカルボニル基、ベンジルオキシカルボニル基、パ
ラメトキシベンジルオキシカルボニル基及びパラニトロ
ベンジルオキシカルボニル基等のアラルキルオキシカル
ボニル基、ホルミル基、アセチル基、プロパノイル基、
t−ブチロイル基、ピバロイル基及びベンゾイル基等の
アシル基、ベンジル基、α−メチルベンジル基、トリチ
ル基、ベンズヒドリル基、パラニトロベンジル基及びパ
ラメトキシベンジル基等のアラルキル基等が挙げられ、
これらの中ではアラルキル基が好ましく、特に、R1
びR2が同時にベンジル基であるのが好ましい。以下、
各反応工程毎に説明する。
When R 1 and R 2 are amino groups, the protective groups include t-butoxycarbonyl, methoxycarbonyl, ethoxycarbonyl and 2,2,2-trichloroethoxycarbonyl. Alkoxycarbonyl groups such as, benzyloxycarbonyl group, aralkyloxycarbonyl groups such as paramethoxybenzyloxycarbonyl group and paranitrobenzyloxycarbonyl group, formyl group, acetyl group, propanoyl group,
t-butyroyl group, acyl groups such as pivaloyl group and benzoyl group, benzyl group, α-methylbenzyl group, trityl group, benzhydryl group, aralkyl groups such as paranitrobenzyl group and paramethoxybenzyl group, and the like.
Among these, an aralkyl group is preferred, and it is particularly preferred that R 1 and R 2 are simultaneously a benzyl group. Less than,
A description will be given for each reaction step.

【0018】式(2)の化合物の製造 式(2)の化合物は、式(1)の化合物を酸の存在下
で、R2−NH2で表わされるアミン化合物と反応させて
製造される。酸としては、ブレーンステッド酸、ルイス
酸のいずれも使用できる。ブレーンステッド酸としては
硫酸、メタンスルホン酸、p−トルエンスルホン酸等
を、ルイス酸としては三フッ化ホウ素、三塩化アルミニ
ウム、五フッ化アンチモン等を挙げられるが、三フッ化
ホウ素が特に好ましい。酸の使用量は通常、式(1)の
化合物に対し1/1000〜1倍モルの範囲でよく、好
ましくは1/100〜1/2倍モル、特に1/10倍モ
ルが好ましい。この反応には溶媒を用いるのが好まし
く、反応に不活性なものであれば特に制限はないが、芳
香族炭化水素系、エーテル系、アミド系、その他、酢酸
エチル等を用いることができるが、ベンゼン、トルエン
等の芳香族炭化水素系が好ましい。また、反応温度は、
酸の種類や使用する溶媒により異なるが、室温〜溶媒の
沸点の範囲で行なえばよい。
Preparation of the compound of formula (2) The compound of formula (2) is prepared by reacting the compound of formula (1) with an amine compound represented by R 2 —NH 2 in the presence of an acid. As the acid, either a Bronsted acid or a Lewis acid can be used. Examples of the Bronsted acid include sulfuric acid, methanesulfonic acid, p-toluenesulfonic acid, and the like, and examples of the Lewis acid include boron trifluoride, aluminum trichloride, and antimony pentafluoride. Boron trifluoride is particularly preferred. The amount of the acid used may usually be in the range of 1/1000 to 1 mole, preferably 1/100 to 1/2 mole, and particularly preferably 1/10 mole relative to the compound of the formula (1). It is preferable to use a solvent for the reaction, and there is no particular limitation as long as the solvent is inert to the reaction. Aromatic hydrocarbons such as benzene and toluene are preferred. The reaction temperature is
Although it depends on the kind of the acid and the solvent used, it may be carried out within a range from room temperature to the boiling point of the solvent.

【0019】光学活性な式(3)の化合物の製造 式(3)の光学活性化合物は、式(2)の化合物を不斉
触媒の存在下で接触還元して製造される。この反応で使
用する不斉触媒は、MXmnで表わされ、周期律表8〜
10族の遷移金属錯体と光学活性ホスフィンとを溶媒中
で反応させたものを単離もしくはそのまま使用する。こ
こで周期律表8〜10族の遷移金属としては、イリジウ
ム、ロジウム、ルテニウム等が好ましい。不斉触媒の使
用量は、式(2)の化合物に対し、1/1000〜1/
2倍モルの範囲でよく、好ましくは1/100〜1/5
倍モル、特に1/10倍モルが好ましい。
Preparation of Optically Active Compound of Formula (3) The optically active compound of formula (3) is produced by catalytic reduction of the compound of formula (2) in the presence of an asymmetric catalyst. Asymmetric catalyst used in this reaction is represented by MX m L n, periodic table 8
A reaction product of a group 10 transition metal complex and an optically active phosphine in a solvent is isolated or used as it is. Here, iridium, rhodium, ruthenium, and the like are preferable as transition metals of Groups 8 to 10 of the periodic table. The amount of the asymmetric catalyst used is 1/1000 to 1/100 with respect to the compound of the formula (2).
It may be in the range of 2 moles, preferably 1/100 to 1/5.
A 1-fold mole, particularly a 1 / 10-fold mole, is preferred.

【0020】第8〜10族遷移金属錯体としては、クロ
ロ(1,5−シクロオクタジエン)イリジウム ダイマ
ー、ビス(1,5−シクロオクタジエン)イリジウム、
テトラフルオロボレート、クロロ(1,5−シクロオク
タジエン)ロジウム ダイマー、ビス(1,5−シクロ
オクタジエン)ロジウム テトラフルオロボレート、ビ
ス(1,5−シクロオクタジエン)ロジウム、トリフル
オロメタンスルフォネート、クロロ(ノルボルナジエ
ン)ロジウム ダイマー、ビス(ノルボルナジエン)ロ
ジウム テトラフルオロボレート、ビス(ノルボルナジ
エン)ロジウムパークロレート、ジクロロ(1,5−シ
クロオクタジエン)ルテニウム、p−シメン ルテニウ
ム クロライド ダイマー、ベンゼン ルテニウム ク
ロライドダイマー等が挙げられるが、特に、クロロ
(1,5−シクロオクタジエン)イリジウム ダイマー
が好ましい。
Examples of the transition metal complexes of Groups 8 to 10 include chloro (1,5-cyclooctadiene) iridium dimer, bis (1,5-cyclooctadiene) iridium,
Tetrafluoroborate, chloro (1,5-cyclooctadiene) rhodium dimer, bis (1,5-cyclooctadiene) rhodium tetrafluoroborate, bis (1,5-cyclooctadiene) rhodium, trifluoromethanesulfonate, Chloro (norbornadiene) rhodium dimer, bis (norbornadiene) rhodium tetrafluoroborate, bis (norbornadiene) rhodium perchlorate, dichloro (1,5-cyclooctadiene) ruthenium, p-cymene ruthenium chloride dimer, benzene ruthenium chloride dimer, etc. However, chloro (1,5-cyclooctadiene) iridium dimer is particularly preferred.

【0021】光学活性ホスフィンとしては、S−及びR
−2,2′−ビス(ジフェニルホスフィノ)−1,1′
−ビナフチル:BINAP、S−及びR−2,2′−ビ
ス(ジ−p−トリルホスフィノ)−1,1′−ビナフチ
ル:tol−BINAP、2S,4S−及び2R,4R
−N−(tert−ブトキシカルボニル)−4−(ジフェニ
ルホスフィノ)−2−[(ジフェニルホスフィノ)メチ
ル]ピロリジン:BPPM、2S,3S−及び2R,3
R−2,3−o−イソプロピリデン−2,3−ジハイド
ロキシ−1,4−ビス(ジフェニルホスフィノ)ブタ
ン:DIOP、2S,3S−及び2R,3R−2,3−
ビス(ジフェニルホスフィノ)ブタン:CHIRAPH
OS、2S,4S−及び2R,4R−2,3−ビス(ジ
フェニルホスフィノ)ペンタン:BDPP、5S,6S
−及び5R,6R−5,6−ビス(ジフェニルホスフィ
ノ)−2−ノルボルネン:NORPHOS、R−1−
[S−1′,2−ビス(ジフェニルホスフィノ)フェロ
セニル]エチルアルコール及びその立体異性体:BPP
FOH、S−1−[R−2−(ジフェニルホスフィノ)
フェロセニル]エチルジシクロヘキシルホスフィン及び
その立体異性体:JOSIPHOS、1,2−ビス
[(2R,5R)−2,5−ジエチルホスフォラノ]エ
タン及びその立体異性体:Et−BPE、1,2−ビス
[(2R,5R)−2,5−ジエチルホスフォラノ]ベ
ンゼン及びその立体異性体:Et−DUPHOS等が使
用できるが、特に、tol−BINAPが好ましい。
The optically active phosphines include S- and R
-2,2'-bis (diphenylphosphino) -1,1 '
-Binaphthyl: BINAP, S- and R-2,2'-bis (di-p-tolylphosphino) -1,1'-binaphthyl: tol-BINAP, 2S, 4S- and 2R, 4R
-N- (tert-butoxycarbonyl) -4- (diphenylphosphino) -2-[(diphenylphosphino) methyl] pyrrolidine: BPPM, 2S, 3S- and 2R, 3
R-2,3-o-isopropylidene-2,3-dihydroxy-1,4-bis (diphenylphosphino) butane: DIOP, 2S, 3S- and 2R, 3R-2,3-
Bis (diphenylphosphino) butane: CHIRAPH
OS, 2S, 4S- and 2R, 4R-2,3-bis (diphenylphosphino) pentane: BDPP, 5S, 6S
-And 5R, 6R-5,6-bis (diphenylphosphino) -2-norbornene: NORPHOS, R-1-
[S-1 ', 2-bis (diphenylphosphino) ferrocenyl] ethyl alcohol and its stereoisomer: BPP
FOH, S-1- [R-2- (diphenylphosphino)
Ferrocenyl] ethyldicyclohexylphosphine and its stereoisomer: JOSIPHOS, 1,2-bis [(2R, 5R) -2,5-diethylphosphorano] ethane and its stereoisomer: Et-BPE, 1,2-bis [(2R, 5R) -2,5-diethylphosphorano] benzene and its stereoisomer: Et-DUPHOS can be used, but tol-BINAP is particularly preferred.

【0022】[0022]

【化17】 Embedded image

【0023】不斉触媒としては、イリジウム−(tol
−BINAP)が好ましい。
As the asymmetric catalyst, iridium- (tol
-BINAP) is preferred.

【0024】この反応には溶媒を用いるのが好ましく、
アルコール系、芳香族炭化水素系、エーテル系、ハロゲ
ン化炭化水素系等を用いることができ、好ましいものを
選択すればよい。また以上の溶媒2種以上を組み合わせ
た混合溶媒であってもよい。水素圧は、常圧〜100気
圧の範囲で行えばよく、好ましくは30気圧〜50気圧
の範囲である。反応温度は、−78℃〜溶媒の沸点の範
囲で行えばよく、好ましくは−30℃〜−10℃の範囲
である。また、この反応は、ヨウ化カリウム等のヨウ化
物、ベンジルアミン等のアミンやテトラn−ブチルアン
モニウムボロハイドライド等のアンモニウム塩を加える
ことによって化学収率及び不斉収率が向上する場合があ
る。
It is preferable to use a solvent for this reaction.
Alcohols, aromatic hydrocarbons, ethers, halogenated hydrocarbons and the like can be used, and preferred ones may be selected. Further, a mixed solvent obtained by combining two or more of the above solvents may be used. The hydrogen pressure may be in the range of normal pressure to 100 atm, preferably in the range of 30 to 50 atm. The reaction temperature may be in the range of -78 ° C to the boiling point of the solvent, preferably in the range of -30 ° C to -10 ° C. In addition, in this reaction, the chemical yield and the asymmetric yield may be improved by adding an iodide such as potassium iodide, an amine such as benzylamine, or an ammonium salt such as tetra-n-butylammonium borohydride.

【0025】光学活性な式(4)の化合物の製造 式(4)の化合物は、式(3)の化合物のR1及び/又
はR2がアミノ基の保護基である場合は、これを水素、
金属触媒存在下で還元することによって製造される。金
属触媒としては、パラジウム炭素、水酸化パラジウム、
パラジウム−硫酸バリウム等のパラジウム系触媒が好ま
しい。この反応には溶媒を用いるのが好ましく、反応に
不活性なものであれば特に制限はないが、アルコール
系、芳香族炭化水素系、エーテル系、アミド系、水、そ
の他、酢酸エチル等を用いることができ、好ましいもの
を選択すればよい。水素圧は常圧〜100気圧の加圧下
で行うことができるが、常圧〜50気圧が好ましい。ま
た、反応温度は、酸の種類や使用する溶媒により異なる
が、室温から溶媒の沸点の範囲で行えばよい。
Preparation of Optically Active Compound of Formula (4) When R 1 and / or R 2 of the compound of formula (3) is an amino-protecting group, the compound of formula (4) is converted to hydrogen. ,
It is produced by reduction in the presence of a metal catalyst. As the metal catalyst, palladium carbon, palladium hydroxide,
Palladium-based catalysts such as palladium-barium sulfate are preferred. It is preferable to use a solvent for this reaction, and there is no particular limitation as long as it is inert to the reaction. However, alcohols, aromatic hydrocarbons, ethers, amides, water, others, and ethyl acetate are used. What is necessary is just to select a preferable thing. The hydrogen pressure can be increased from normal pressure to 100 atm, preferably from normal pressure to 50 atm. The reaction temperature varies depending on the type of acid and the solvent used, but may be in the range of room temperature to the boiling point of the solvent.

【0026】なお、ここにはイミン化合物を一旦調製し
た後に不斉還元する経路を示したが、化合物(1)及び
アミン化合物、酸、そして不斉触媒の存在下で水素雰囲
気下に処理することで一気にこれらの反応を行うことも
できる。
Although the route for asymmetric reduction after the preparation of the imine compound is shown here, it is necessary to treat the compound (1) and an amine compound, an acid and an asymmetric catalyst in a hydrogen atmosphere. These reactions can be performed all at once.

【0027】本発明の製造法で製造された7−アミノ−
5−アザスピロ[2.4]ヘプタンは、塩酸、硫酸、硝
酸等の無機酸や、置換カルボン酸類、置換スルホン酸類
等の有機酸等の塩としてもよい。
7-amino-produced by the process of the present invention
5-Azaspiro [2.4] heptane may be in the form of a salt such as an inorganic acid such as hydrochloric acid, sulfuric acid or nitric acid, or an organic acid such as substituted carboxylic acids and substituted sulfonic acids.

【0028】[0028]

【実施例】次に実施例を挙げて本発明を説明するが、本
発明はこれに限定されるものではない。
Next, the present invention will be described with reference to examples, but the present invention is not limited to these examples.

【0029】実施例1 N−ベンジル−N−(5−ベンジル−5−アザスピロ
[2.4]ヘプト−7−イリデン)アミンの合成 5−ベンジル−5−アザスピロ[2.4]ヘプタン−7
−オン(1g)、ベンジルアミン(642mg)のベンゼ
ン(10mL)溶液に三フッ化ホウ素・エーテル溶液
(0.1mL)を加え、Dean−Stark還流器を取
り付け、4時間加熱還流した。溶媒を減圧留去後、残渣
をシリカゲルカラムクロマトグラフィーに付し、n−ヘ
キサン:酢酸エチル=2:1で展開することにより、標
題化合物を黄色油状物質として952mg得た。1 H-NMR(CDCl3)δ:0.85(dd,J=3.0,5.1Hz,2H), 1.18(dd,
J=3.0,5.1Hz,2H), 2.83(s,2H), 3.39(s,2H), 3.73(s,2
H), 4.39(s,2H), 7.18-7.38(m,10H).
Example 1 Synthesis of N-benzyl-N- (5-benzyl-5-azaspiro [2.4] hept-7-ylidene) amine 5-benzyl-5-azaspiro [2.4] heptane-7
To a solution of -one (1 g) and benzylamine (642 mg) in benzene (10 mL) was added a boron trifluoride / ether solution (0.1 mL), and a Dean-Stark reflux condenser was attached, followed by heating under reflux for 4 hours. After evaporating the solvent under reduced pressure, the residue was subjected to silica gel column chromatography and developed with n-hexane: ethyl acetate = 2: 1 to obtain 952 mg of the title compound as a yellow oil. 1 H-NMR (CDCl 3 ) δ: 0.85 (dd, J = 3.0, 5.1 Hz, 2H), 1.18 (dd,
J = 3.0,5.1Hz, 2H), 2.83 (s, 2H), 3.39 (s, 2H), 3.73 (s, 2
H), 4.39 (s, 2H), 7.18-7.38 (m, 10H).

【0030】実施例2〜8 N−ベンジル−N−(5−ベンジル−5−アザスピロ
[2.4]ヘプト−7−イリデン)アミンの不斉還元 [Ir(COD)Cl]2(30.9mg)のエタノール
(4.5mL)溶液にR−tol−BINAP(67.9
mg)を加え、室温下2時間攪拌し触媒の調製を行った。
オートクレーブにN−ベンジル−N−(5−ベンジル−
5−アザスピロ[2.4]ヘプト−7−イリデン)アミ
ン(290mg)のエタノール(4.5mL)溶液、調製し
た触媒溶液を仕込み、水素圧30気圧、−10℃で63
時間攪拌した。溶媒を減圧留去後、残渣をシリカゲルカ
ラムクロマトグラフィーに付し、クロロホルム:メタノ
ール=10:1で展開することにより、N−ベンジル−
N−(5−ベンジル−5−アザスピロ[2.4]ヘプタ
ン−7−イル)アミンを黄色油状物質として187mg得
た。1 H-NMR(CDCl3)δ:0.35-0.42(m,1H), 0.51-0.64(m,2H),
0.86-0.91(m,2H), 2.56(dd,J=8.9,43.6Hz), 2.55(dd,J
=4.0,4.0Hz,1H), 3.00-3.10(m,2H), 3.64(d,J=8.6Hz,2
H), 3.71(dd,J=13.2,43.6Hz,2H), 7.10-7.36(m,10H). 得られたアミンの光学純度及び変換率は液体クロマトグ
ラフィーにて分析を行った。 カラム:CHIRALPAK AD−RH(ダイセル化
学社製) 展開溶媒:アセトニトリル:リン酸緩衝液(pH7.0)
=2:3(容量比) 流速:1.0mL/分
Examples 2 to 8 Asymmetric reduction of N-benzyl-N- (5-benzyl-5-azaspiro [2.4] hept-7-ylidene) amine [Ir (COD) Cl] 2 (30.9 mg ) Was added to a solution of R-tol-BINAP (67.9) in ethanol (4.5 mL).
mg) and stirred at room temperature for 2 hours to prepare a catalyst.
The autoclave was charged with N-benzyl-N- (5-benzyl-
A solution of 5-azaspiro [2.4] hept-7-ylidene) amine (290 mg) in ethanol (4.5 mL) and the prepared catalyst solution were charged, and a hydrogen pressure of 30 atm.
Stirred for hours. After evaporating the solvent under reduced pressure, the residue was subjected to silica gel column chromatography and developed with chloroform: methanol = 10: 1 to give N-benzyl-
187 mg of N- (5-benzyl-5-azaspiro [2.4] heptan-7-yl) amine were obtained as a yellow oil. 1 H-NMR (CDCl 3) δ: 0.35-0.42 (m, 1H), 0.51-0.64 (m, 2H),
0.86-0.91 (m, 2H), 2.56 (dd, J = 8.9,43.6Hz), 2.55 (dd, J
= 4.0,4.0Hz, 1H), 3.00-3.10 (m, 2H), 3.64 (d, J = 8.6Hz, 2
H), 3.71 (dd, J = 13.2, 43.6 Hz, 2H), 7.10-7.36 (m, 10H). The optical purity and conversion of the obtained amine were analyzed by liquid chromatography. Column: CHIRALPAK AD-RH (manufactured by Daicel Chemical Industries) Developing solvent: acetonitrile: phosphate buffer (pH 7.0)
= 2: 3 (volume ratio) Flow rate: 1.0 mL / min

【0031】配位子、溶媒、添加剤を変え、同様の反応
を行った結果を表1に示す。
Table 1 shows the results of the same reaction when the ligand, the solvent and the additive were changed.

【0032】[0032]

【表1】 [Table 1]

【0033】実施例9 7−アミノ−5−アザスピロ[2.4]ヘプタン・2塩
酸塩 N−ベンジル−N−(5−ベンジル−5−アザスピロ
[2.4]ヘプタン−7−イル)アミン[170mg、5
3%e.e.(S)]、5%Pd−C(17mg)のトルエン
(2mL)懸濁液に濃塩酸(0.58mL)を加え、水素雰
囲気下5時間攪拌した。触媒をろ去後、ろ液を放冷し、
イソプロピルアルコール(5mL)を加え、3時間攪拌し
た。析出物をろ取し、既知である標題化合物を白色結晶
として177mg得た。特開平4−149174号公報に
記載された方法で、得られたアミンの一部を3,5−ジ
ニトロベンゾイルクロライドでアシル化後、液体クロマ
トグラフィーにて光学純度測定を行った結果、53%e.
e.、絶対配置はS体であった。
Example 9 7-Amino-5-azaspiro [2.4] heptane dihydrochloride N-benzyl-N- (5-benzyl-5-azaspiro [2.4] heptane-7-yl) amine [ 170 mg, 5
[3% ee (S)]] To a suspension of 5% Pd-C (17 mg) in toluene (2 mL) was added concentrated hydrochloric acid (0.58 mL), and the mixture was stirred for 5 hours under a hydrogen atmosphere. After removing the catalyst by filtration, the filtrate is allowed to cool,
Isopropyl alcohol (5 mL) was added, and the mixture was stirred for 3 hours. The precipitate was collected by filtration to obtain 177 mg of the known title compound as white crystals. A part of the obtained amine was acylated with 3,5-dinitrobenzoyl chloride by the method described in JP-A-4-149174, and the optical purity was measured by liquid chromatography. As a result, 53% e was obtained. .
e. The absolute configuration was S-form.

【0034】[0034]

【発明の効果】本発明の製造法は、触媒量の不斉源を用
いることで高収率で光学純度の高い光学活性7−アミノ
−5−アザスピロ[2.4]ヘプタンを製造できる。ま
た式(2)の化合物は抗菌性化合物の製造中間体として
有用である。
According to the production method of the present invention, an optically active 7-amino-5-azaspiro [2.4] heptane having high optical purity and high optical purity can be produced by using a catalytic amount of an asymmetric source. Further, the compound of the formula (2) is useful as an intermediate for producing an antibacterial compound.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 秋葉 敏文 東京都江戸川区北葛西1丁目16番13号 第 一製薬株式会社東京研究開発センター内 Fターム(参考) 4C204 AB20 BB04 CB10 DB31 EB02 FB01 GB01 4G069 AA06 BA27A BA27B BC65A BC69A BC70A BC71A BC74A BC74B BE03A BE04A BE04B BE26A BE27A BE27B BE37A BE37B BE46A BE46B CB57 4H006 AA02 AC80 AC81 4H039 CA71 CB30  ──────────────────────────────────────────────────続 き Continuing on the front page (72) Inventor Toshifumi Akiba 1-16-13 Kita-Kasai, Edogawa-ku, Tokyo F-term in Tokyo Research & Development Center, Daiichi Pharmaceutical Co., Ltd. 4C204 AB20 BB04 CB10 DB31 EB02 FB01 GB01 4G069 AA06 BA27A BA27B BC65A BC69A BC70A BC71A BC74A BC74B BE03A BE04A BE04B BE26A BE27A BE27B BE37A BE37B BE46A BE46B CB57 4H006 AA02 AC80 AC81 4H039 CA71 CB30

Claims (11)

【特許請求の範囲】[Claims] 【請求項1】 次式(1) 【化1】 (式中、R1は水素原子又はアミノ基の保護基を示
す。)で表わされる化合物に、酸存在下で、式 R2
NH2(式中、R2は水素原子又はアミノ基の保護基を示
す。)で表わされる化合物を反応させ、得られた式
(2) 【化2】 (式中、R1及びR2は各々独立して前記と同じ。)で表
わされる化合物を、式MXmn(式中、Mは周期律表8
〜10族の遷移金属、Xは水素原子、ハロゲン原子、ア
ルコキシ基、アルケニル基又はアリール基、Lは光学活
性ホスフィン配位子を示し、m及びnは各々0〜6の整
数を示す。)で表わされる不斉触媒の存在下で還元し、
得られた式(3) 【化3】 (式中、R1及びR2は各々独立して前記と同じ。)で表
わされる化合物を、所望により脱保護することを特徴と
する式(4) 【化4】 で表わされる光学活性化合物の製造法。
1. The following formula (1) (Wherein R 1 represents a hydrogen atom or an amino-protecting group) in the presence of an acid in the presence of a compound represented by the formula R 2-
A compound represented by NH 2 (wherein R 2 represents a hydrogen atom or an amino-protecting group) is reacted to obtain a compound of the formula (2) (Wherein R 1 and R 2 are each independently the same as described above), and a compound represented by the formula MX m L n (where M is the periodic table 8)
Group X to X transition metals, X represents a hydrogen atom, a halogen atom, an alkoxy group, an alkenyl group or an aryl group, L represents an optically active phosphine ligand, and m and n each represent an integer of 0-6. ) In the presence of an asymmetric catalyst represented by
The obtained formula (3) (Wherein, R 1 and R 2 are each independently the same as defined above), wherein the compound represented by the formula (4) is optionally deprotected. A method for producing an optically active compound represented by the formula:
【請求項2】 R1及びR2のアミノ基の保護基が、アル
コキシカルボニル基、アラルキルオキシカルボニル基、
アシル基又はアラルキル基である請求項1記載の光学活
性化合物の製造法。
2. The amino-protecting group for R 1 and R 2 is an alkoxycarbonyl group, an aralkyloxycarbonyl group,
The method for producing an optically active compound according to claim 1, which is an acyl group or an aralkyl group.
【請求項3】 R1及びR2がアラルキル基である請求項
1又は2記載の光学活性化合物の製造法。
3. The method for producing an optically active compound according to claim 1, wherein R 1 and R 2 are aralkyl groups.
【請求項4】 R1及びR2がベンジル基である請求項1
〜3のいずれか一項に記載の光学活性化合物の製造法。
4. The method according to claim 1, wherein R 1 and R 2 are benzyl groups.
4. The method for producing an optically active compound according to any one of items 3 to 3.
【請求項5】 次式(2) 【化5】 (式中、R1及びR2は各々独立して水素原子又はアミノ
基の保護基を示す。)で表わされる化合物。
5. The following formula (2): (Wherein, R 1 and R 2 each independently represent a hydrogen atom or an amino-protecting group).
【請求項6】 R1及びR2のアミノ基の保護基が各々独
立してアルコキシカルボニル基、アラルキルオキシカル
ボニル基、アシル基又はアラルキル基である請求項5記
載の化合物。
6. The compound according to claim 5, wherein the amino-protecting groups for R 1 and R 2 are each independently an alkoxycarbonyl group, an aralkyloxycarbonyl group, an acyl group or an aralkyl group.
【請求項7】 R1及びR2がアラルキル基である請求項
5又は6記載の化合物。
7. The compound according to claim 5, wherein R 1 and R 2 are an aralkyl group.
【請求項8】 R1及びR2がベンジル基である請求項5
〜7のいずれか一項に記載の化合物。
8. The method according to claim 5, wherein R 1 and R 2 are benzyl groups.
A compound according to any one of claims 1 to 7.
【請求項9】 次式(1) 【化6】 (式中、R1は水素原子又はアミノ基の保護基を示
す。)で表わされる化合物に、酸存在下で、式 R2
NH2(式中、R2は水素原子又はアミノ基の保護基を示
す。)で表わされる化合物を反応させることを特徴とす
る式(2) 【化7】 (式中、R1及びR2は各々独立して前記と同じ。)で表
わされる化合物の製造法。
9. The following formula (1) (Wherein R 1 represents a hydrogen atom or an amino-protecting group) in the presence of an acid in the presence of a compound represented by the formula R 2-
Reacting a compound represented by NH 2 (wherein R 2 represents a hydrogen atom or a protecting group for an amino group), characterized by the following formula (2): (Wherein, R 1 and R 2 are each independently the same as described above).
【請求項10】 次式(2) 【化8】 (式中、R1及びR2は各々独立して水素原子又はアミノ
基の保護基を示す。)で表わされる化合物を、式 MX
mn(式中、Mは周期律表8〜10族の遷移金属、Xは
水素原子、ハロゲン原子、アルコキシ基、アルケニル基
又はアリール基、Lは光学活性ホスフィン配位子を示
し、m及びnは各々0〜6の整数を示す。)で表わされ
る不斉触媒の存在下で水素還元することを特徴とする式
(3) 【化9】 (式中、R1及びR2は前記と同じ。)で表わされる光学
活性化合物の製造法。
10. The following formula (2) (Wherein R 1 and R 2 each independently represent a hydrogen atom or an amino-protecting group).
m L n (wherein, M is a transition metal of Groups 8 to 10 of the periodic table, X is a hydrogen atom, a halogen atom, an alkoxy group, an alkenyl group or an aryl group, L is an optically active phosphine ligand, m and wherein n is an integer of 0 to 6), wherein hydrogen reduction is carried out in the presence of an asymmetric catalyst represented by the following formula (3): (Wherein R 1 and R 2 are the same as described above).
【請求項11】 次式(3) 【化10】 (式中、R1及びR2は各々独立して水素原子又はアミノ
基の保護基を示す。但し、R1及びR2が同時に水素原子
である場合を除く。)で表わされる光学活性化合物を、
脱保護することを特徴とする式(4) 【化11】 で表わされる光学活性の製造法。
11. The following formula (3): (Wherein, R 1 and R 2 each independently represent a hydrogen atom or a protecting group for an amino group, provided that R 1 and R 2 are not simultaneously a hydrogen atom). ,
Formula (4) characterized by deprotection Production method of optical activity represented by
JP2001050384A 2001-02-26 2001-02-26 Method for producing optically active 7-amino-5- azaspiro[2.4]heptane Pending JP2002255933A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001050384A JP2002255933A (en) 2001-02-26 2001-02-26 Method for producing optically active 7-amino-5- azaspiro[2.4]heptane

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001050384A JP2002255933A (en) 2001-02-26 2001-02-26 Method for producing optically active 7-amino-5- azaspiro[2.4]heptane

Publications (1)

Publication Number Publication Date
JP2002255933A true JP2002255933A (en) 2002-09-11

Family

ID=18911346

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001050384A Pending JP2002255933A (en) 2001-02-26 2001-02-26 Method for producing optically active 7-amino-5- azaspiro[2.4]heptane

Country Status (1)

Country Link
JP (1) JP2002255933A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004099184A1 (en) * 2003-05-12 2004-11-18 Nihon Nohyaku Co., Ltd. Process for producing substituted aminoquinazolinone derivative, intermediate therefor, and pest control agent
JP2004359673A (en) * 2003-05-12 2004-12-24 Nippon Nohyaku Co Ltd Method for producing substituted aminoquinazolinone derivative
JP2011525923A (en) * 2008-06-27 2011-09-29 メルク フロスト カナダ リミテツド Synthesis of chiral amines

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004099184A1 (en) * 2003-05-12 2004-11-18 Nihon Nohyaku Co., Ltd. Process for producing substituted aminoquinazolinone derivative, intermediate therefor, and pest control agent
JP2004359673A (en) * 2003-05-12 2004-12-24 Nippon Nohyaku Co Ltd Method for producing substituted aminoquinazolinone derivative
CN1823055B (en) * 2003-05-12 2010-11-24 日本农药株式会社 Process for producing substituted aminoquinazolinone derivative, intermediate therefor, and pest control agent
US8034931B2 (en) 2003-05-12 2011-10-11 Nihon Nohyaku Co., Ltd. Process for producing substituted aminoquinazolinone derivative, intermediate therefor, and pest control agent
JP2011525923A (en) * 2008-06-27 2011-09-29 メルク フロスト カナダ リミテツド Synthesis of chiral amines

Similar Documents

Publication Publication Date Title
JP2014525408A (en) Synthesis of R-biphenylalaninol
ES2545903T3 (en) Asymmetric urea compounds and process for producing asymmetric compounds by reaction of asymmetric addition of conjugate using said compounds as catalyst
US20050159604A1 (en) Asymmetric hydrogenation of alpha-amino carbonyl compounds
EP0860432B1 (en) 2-Phenyl-2-(2&#39;-piperidinylidene) acetate derivative, process for manufacturing the same, and process for manufacturing optically active 2-phenyl-2(2&#39;-piperidinyl) acetate derivative by asymmetrically hydrogenating the same
EP0672649B1 (en) Process for producing optically active diaminohexanone derivative
JP2002255933A (en) Method for producing optically active 7-amino-5- azaspiro[2.4]heptane
JP5001263B2 (en) Asymmetric hydrogenation for the preparation of diphenylalanine derivatives
JP2004099609A (en) Method for producing optically active 7-amino-5-azaspiro[2.4]heptane
JP3088328B2 (en) Method for producing optically active 2-phenyl-2- (2&#39;-piperidinyl) acetic acid ester derivative
JPH08311001A (en) Production of optically active amine
US6593489B1 (en) Substituted cyclopentenes, their preparation and their use for chiral scaffolds
KR102590897B1 (en) Method for producing chiral gamma-lactam compound and metal complex therefor
JPH10279552A (en) 7-(n-substituted amino)-2-phenylheptanoic acid ester derivative and production of the derivative
Tanimori et al. A simple and easy access to 3-N-alkyl-5-vinyloxazolidinones mediated by palladium–phosphine catalysts
KR101057304B1 (en) Method for preparing aspartic acid derivative using chiral catalyst
US5942629A (en) Process for producing optically active pyrrolidine derivatives
Olszewska et al. Diastereoselective synthesis of 2-vinylpyrrolidines and 2-vinylpiperidines by the palladium-catalysed cyclization of amino-allylic carbonates containing a chiral protecting group
JP4187822B2 (en) Process for producing optically active 4-hydroxy-2-pyrrolidone
EA004927B1 (en) PROCESS FOR THE SYNTHESIS OF (3aS)-5,5-DIOXO-2,3,3a,4-TETRAHYDRO-1H-PYRROLO[2,1-c][1,2,4]BENZOTHIADIAZINE
EP3819295A1 (en) Stereoselective synthesis of enantiomerically-enriched pantolactone
JP2003212874A (en) Method for producing isoquinuclidine derivative
JP3088334B2 (en) 2-phenyl-2- (2&#39;-piperidinylidene) acetic acid ester derivative and method for producing the derivative
JP2020131172A (en) Organic molecular catalyst and its use to achieve highly stereoselective asymmetric aldol reaction
JP2005097202A (en) Method for producing optically active lactam derivative by catalytic asymmetrical hydrogenation
JPH03176463A (en) Pyrrolidinol derivative and its production